Sponsors

Panel for interfering substances

Firefly Scientific has launched its OptiChallenge Inhibition Panel for use in evaluating the performance of an assay in the presence of interfering substances.

The sevenmember panel is the very first to provide quantified amounts of commonly recognised inhibitors. The panel members represent elevated levels of inhibitory substances encountered routinely in the normal patient population.

Interfering substances such as heparin, lipids, bilirubin and haemolysed plasma are found commonly in patient samples. At minimal levels, these substances do not interfere with assay results. However, when levels become elevated due to the effect of lifestyle or medications, these substances can hinder the amplification of nucleic acid assays. Studies show that 12.5% of incorrect and delayed test results affect patient health.

The OptiChallenge Inhibition Panel allows laboratories to identify limitations in testing due to the presence of interfering substances and enables appropriate actions to be taken.

www.fireflyscientific.co.uk

Latest Issues

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

37th European Congress of Pathology

ACV, Vienna, Austria
6 -10 September, 2025